The US regulator announced Monday to authorize a new drug against Alzheimer's disease, for the first time in nearly two decades.
Read alsoThe surprising decline of Alzheimer's disease
This clearance is significant in many ways
,” the US Drug Administration (FDA) said in a statement.
The drug, named Aduhelm and produced by pharmaceutical company Biogen, "
is the first approved treatment for Alzheimer's disease since 2003
," the FDA said.